China National Intellectual Property Administration Grants Vyome Patent Chinese Patent No. ZL 2021 1 0758695.X
Newly granted Chinese patent broadens Vyome's intellectual property estate with additional formulation and therapeutic use claims for besifloxacin gel in inflammatory acne, supporting future partnering, licensing and regional commercialization for this $600 million market VT-1953 for malignant fungating wounds remains Vyome's flagship program and primary capital allocation priority
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.